Sign in

NCT04439708Recruiting

Biomarkers and Choroidal Neovascularization

Biomarkers Analysis of Mineralocortoid Receptor Activation in the Serum and Ocular Fluid of Patients With Choroidal Neovascularization

Source: ClinicalTrials.gov · Last updated 7 Jul 2026

Brief summary (registry, in English)

The aim of the study is to find biomarkers in the blood and aqueous humor of patients with type 1 choroidal neovascularization and correlate them with the response to anti-VEGF treatment.

Status (registry)
Recruiting
Study type
Observational
Enrollment
250 (estimated)
First submitted
2 Mar 2020
Start date
6 Jul 2020
Primary completion date
6 Jan 2027
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
NCT number
NCT04439708

What you commit to

  • Study type: Observational
  • Planned participants: 250
  • From 6 Jul 2020 to the primary completion date, 6 Jan 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Myocardial infarction \< 12 months
  • Chronic renal failure
  • Inflammatory disease
  • Infectious disease :HIV, viral hepatitis, tuberculosis
  • Type 1 or 2 Diabetes

Other

  • Patients treated by mineralocorticoid antagonist treatment.
  • Type 2 or 3 choroidal neovascularization
  • Pregnant woman

Who the study is looking for

  • Patients of group 1:
  • Patients with type 1 choroidal neovascularization in a context of central serous chorioretinoathy or age related macular degeneration
  • Patients without intravitreal injection or last intravitreal injection \> 3 months
  • Informed signed consent
    • Patients of group 2:
  • Patients without choroidal neovascularization
  • Patients with intraocular surgery (cataract or vitrectomy surgery)
  • Signed consent

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ophtalmopole Hôpital Cochin
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Hopital Foch
Coordinator of this site? Confirm its status
SuresnesFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.